Results 221 to 230 of about 61,255 (306)

Balancing benefit and burden: treatment intensification in paediatric KMT2A rearrangements acute myeloid leukaemia. [PDF]

Acta Oncol
Fayez H, Elsherif M, Salem S, Elsharkawy N, Elnashar A, Kamal M, Khedr R, Lehmann L, Ahmed S, Elhaddad A.   +9 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1. [PDF]

Clin Transl Immunology
Wu Y, Yuan X, Lai X, Liu L, Liang Y, Ni L, Yang L, Hu S, Shi J, Yu J, Zhao Y, Zheng W, Sun J, Zhu Y, Wu W, Cai Z, Huang H, Pei S, Luo Y.   +18 more
europepmc   +1 more source

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

Med Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu, Haini Zhang, Shuang Luo, Xiangmei Zhang, Mei Tan, Jinmei Chen, Pei Huang, Yan Chen, Zuochen Du   +8 more
wiley   +1 more source

Bioinformatics differential expression analysis of the effect of cannabidiol in chronic myeloid leukaemia cell line. [PDF]

Glob Med Genet
Donchev PP, Danova ST.
europepmc   +1 more source

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

, 2007
信宏 兼村
openalex   +1 more source

Machine Learning for Predictive Modeling in Nanomedicine‐Based Cancer Drug Delivery

Med Research, EarlyView.
The integration of AI/ML into nanomedicine offers a transformative approach to therapeutic design and optimization. Unlike conventional empirical methods, AI/ML models (such as classification, regression, and neural networks) enable the analysis of complex clinical and formulation datasets to predict optimal nanoparticle characteristics and therapeutic
Rohan Chand Sahu, Sanchit Arora, Dinesh Kumar, Ashish Kumar Agrawal   +3 more
wiley   +1 more source

Prognostic scoring systems in chronic myeloid leukaemia. [PDF]

Leukemia
Lauseker M, Hoffmann VS, Pfirrmann M.
europepmc   +1 more source

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

Med Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang   +8 more
wiley   +1 more source

Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine/cytarabine-based salvage regimens against acute myeloid leukaemia. [PDF]

Br J Haematol
Lilienthal I, Tao S, Nilsson C, Leonard E, Zhang R, Sorteberg AL, Fredrikson L, Xagoraris I, Fard SS, Tsesmetzis N, Zachariadis V, Cai H, Sandhow L, Langebäck A, Bohlin A, Tamm KP, Bengtzén S, Schinazi RF, Lehmann S, Kim B, Rassidakis GZ, Qian H, Jädersten M, Herold N.   +23 more
europepmc   +1 more source